STRS OHIO - ULTRAGENYX PHARMACEUTICAL IN ownership

ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 171 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q2 2019. The put-call ratio across all filers is 0.91 and the average weighting 0.1%.

Quarter-by-quarter ownership
STRS OHIO ownership history of ULTRAGENYX PHARMACEUTICAL IN
ValueSharesWeighting
Q1 2021$2,356,000
-9.9%
20,700
+9.5%
0.01%
-10.0%
Q4 2020$2,616,000
+56.8%
18,900
-6.9%
0.01%
+42.9%
Q3 2020$1,668,000
+148.2%
20,300
+136.0%
0.01%
+133.3%
Q2 2020$672,000
+244.6%
8,600
+95.5%
0.00%
+200.0%
Q1 2020$195,000
+170.8%
4,400
+158.8%
0.00%
Q4 2019$72,000
-66.0%
1,700
-66.0%
0.00%
Q3 2019$212,000
-41.3%
5,000
-12.3%
0.00%
-100.0%
Q2 2019$361,000
-8.6%
5,7000.0%0.00%0.0%
Q1 2019$395,000
+441.1%
5,700
+235.3%
0.00%
Q4 2018$73,000
-82.6%
1,700
-69.1%
0.00%
-100.0%
Q3 2018$419,000
-0.7%
5,5000.0%0.00%0.0%
Q2 2018$422,000
+591.8%
5,500
+358.3%
0.00%
Q1 2018$61,000
+306.7%
1,200
+300.0%
0.00%
Q3 2017$15,000
-92.2%
300
-90.3%
0.00%
-100.0%
Q2 2017$192,000
-8.6%
3,1000.0%0.00%0.0%
Q1 2017$210,000
+7.1%
3,100
+10.7%
0.00%0.0%
Q4 2016$196,000
-27.1%
2,800
-26.3%
0.00%0.0%
Q3 2016$269,000
-12.7%
3,800
-39.7%
0.00%0.0%
Q2 2016$308,000
-66.7%
6,300
-56.8%
0.00%
-75.0%
Q1 2016$924,000
-45.4%
14,600
-3.3%
0.00%
-50.0%
Q4 2015$1,693,000
+16.4%
15,1000.0%0.01%
+14.3%
Q3 2015$1,454,000
-0.7%
15,100
+5.6%
0.01%
+16.7%
Q2 2015$1,464,000
+77.5%
14,300
+7.5%
0.01%
+50.0%
Q1 2015$825,00013,3000.00%
Q3 2014$000.00%
Other shareholders
ULTRAGENYX PHARMACEUTICAL IN shareholders Q2 2019
NameSharesValueWeighting ↓
EcoR1 Capital, LLC 519,119$40,605,0003.00%
First Light Asset Management, LLC 236,958$18,535,0002.16%
SECTOR GAMMA AS 108,734$8,505,0001.76%
Rock Springs Capital Management LP 646,841$50,596,0001.39%
Atika Capital Management LLC 79,000$6,180,0000.80%
Capital Impact Advisors, LLC 30,582$2,392,0000.80%
FEDERATED HERMES, INC. 4,080,359$319,166,0000.79%
Rhenman & Partners Asset Management AB 61,500$4,811,0000.52%
Ikarian Capital, LLC 73,500$5,749,0000.46%
Capital International, Inc./CA/ 477,858$37,378,0000.46%
View complete list of ULTRAGENYX PHARMACEUTICAL IN shareholders